ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer

Wang, Jiao; Huang, Qiong; Hu, Xingbin; Zhang, Shuyi; Jiang, Yu; Yao, Guangyu; Hu, Kongzhen; Xu, Xin; Liang, Bishan; Wu, Qijing; Ma, Zhenfeng; Wang, Yawen; Wang, Chunlin; Wu, Zhenzhen; Rong, Xiaoxiang; Liao, Wangjun; Shi, Min*南方医科大学
Cancer Research2022-4-15DOI: 10.1158/0008-5472.CAN-21-1820
20被引3阅读
引用收藏
分享

摘要

Trastuzumab is the only approved targeted drug for first-line treatment of HER2-positive advanced gastric cancer, but the high rate of primary resistance and rapid emergence of secondary resistance limit its clinical benefits. We found that trastuzumabresistant (TR) gastric cancer cells exhibited high glycolytic activity, which was controlled by hexokinase 2 (HK2)-dependent glycolysis with a circadian pattern [higher at zeitgeber time (ZT) 6, lower at ZT18]. Mechanistically, HK2 circadian oscillation was regulated by a transcriptional complex composed of PPARg and the core clock gene PER1. In vivo and in vitro experiments demonstrated that silencing PER1 disrupted the circadian rhythm of PER1-HK2 and reversed trastuzumab resistance. Moreover, metformin, which inhibits glycolysis and PER1, combined with trastuzumab at ZT6, significantly improved trastuzumab efficacy in gastric cancer. Collectively, these data introduce the circadian clock into trastuzumab therapy and propose a potentially effective chronotherapy strategy to reverse trastuzumab resistance in gastric cancer. @@@ Significance: In trastuzumab-resistant HER2-positive gastric cancer, glycolysis fluctuates with a circadian oscillation regulated by the BMAL1-CLOCK-PER1-HK2 axis, which can be disrupted with a metformin-based chronotherapy to overcome trastuzumab resistance.

学科与关键词

关键词
CLOCK GENE BMAL1BREAST-CANCERMETFORMINMETABOLISMMECHANISMSEXPRESSIONPROTEINGROWTHKINASE
相关
加载中…
  • Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation
    Yao, Xingxing; He, Zhanke; Qin, Caolitao; Zhang, Penghao; Sui, Chuyang; Deng, Xiangqian; Fang, Yuxin; Li, Guoxin*; Shi, Jiaolong*British Journal of Cancer, 2022, 127(5): 811-823.被引 4
  • Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer
    Hu, Xingbin; Ma, Zhenfeng; Xu, Beibei; Li, Shulong; Yao, Zhiqi; Liang, Bishan; Wang, Jiao; Liao, Wangjun; Lin, Li; Wang, Chunling; Zheng, Siting; Wu, Qijing; Huang, Qiong; Yu, Le; Wang, Fenghua*; Shi, Min*Cancer Communications, 2023, 43(8): 909-937.被引 2
  • miR-301a-3p induced by endoplasmic reticulum stress mediates the occurrence and transmission of trastuzumab resistance in HER2-positive gastric cancer
    Guo, Jing; Zhong, Xuxian; Tan, Qinglin; Yang, Shengnan; Liao, Jiaqi; Zhuge, Jinke; Hong, Ziyang; Deng, Qiong; Zuo, Qiang*Cell Death & Disease, 2021, 12(7): 696.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Research
发表日期
2022-04-15
卷期
第 82 卷, 第 8 期
页码
1503-1517
DOI
10.1158/0008-5472.CAN-21-1820
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82073325]; Wu Jieping Medical Foundation [3206750202011018]; Chinese Society of Clinical Oncology Foundation [Y-HR2018-192]

作者

  • W

    Wang, Jiao (第一作者)

    southern med univ

  • H

    Huang, Qiong

    southern med univ

查看全部 17 位作者收起作者
  • H

    Hu, Xingbin

    southern med univ

  • Z

    Zhang, Shuyi

    huizhou municipal cent hosp

  • J

    Jiang, Yu

    southern med univ

  • Y

    Yao, Guangyu

    southern med univ

  • H

    Hu, Kongzhen

    southern med univ

  • X

    Xu, Xin

    southern med univ

  • L

    Liang, Bishan

    southern med univ

  • W

    Wu, Qijing

    southern med univ

  • M

    Ma, Zhenfeng

    southern med univ

  • W

    Wang, Yawen

    southern med univ

  • W

    Wang, Chunlin

    southern med univ

  • W

    Wu, Zhenzhen

    southern med univ

  • R

    Rong, Xiaoxiang

    southern med univ

  • L

    Liao, Wangjun

    southern med univ

  • S

    Shi, Min (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417